Cite
CDKN2A/p16INK4a DELETION IS NOT A POOR PROGNOSTIC FACTOR IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS TREATED ACCORDING TO PROTOCOL RALL-2009
MLA
I. S. Piskunova, et al. “CDKN2A/P16INK4a DELETION IS NOT A POOR PROGNOSTIC FACTOR IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS TREATED ACCORDING TO PROTOCOL RALL-2009.” Онкогематология, vol. 12, no. 3, Oct. 2017, pp. 17–24. EBSCOhost, https://doi.org/10.17650/1818-8346-2017-12-3-17-24.
APA
I. S. Piskunova, T. N. Obukhova, E. N. Parovichnikova, S. M. Kulikov, O. A. Gavrilina, I. A. Lukyanova, & V. G. Savchenko. (2017). CDKN2A/p16INK4a DELETION IS NOT A POOR PROGNOSTIC FACTOR IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS TREATED ACCORDING TO PROTOCOL RALL-2009. Онкогематология, 12(3), 17–24. https://doi.org/10.17650/1818-8346-2017-12-3-17-24
Chicago
I. S. Piskunova, T. N. Obukhova, E. N. Parovichnikova, S. M. Kulikov, O. A. Gavrilina, I. A. Lukyanova, and V. G. Savchenko. 2017. “CDKN2A/P16INK4a DELETION IS NOT A POOR PROGNOSTIC FACTOR IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS TREATED ACCORDING TO PROTOCOL RALL-2009.” Онкогематология 12 (3): 17–24. doi:10.17650/1818-8346-2017-12-3-17-24.